Stayble Therapeutics AB (publ) (FRA:4K4)

Market Cap	1.46M
Revenue (ttm)	n/a
Net Income (ttm)	-761.30K
Shares Out	n/a
EPS (ttm)	-0.01
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	66
Open	0.0194
Previous Close	0.0202
Day's Range	0.0194 - 0.0210
52-Week Range	0.0127 - 0.0528
Beta	n/a
RSI	47.26
Earnings Date	Feb 20, 2026

About Stayble Therapeutics AB

Stayble Therapeutics AB (publ) develops injectable treatment for chronic pain triggered by disc degeneration. The company develops STA363, an injection into the disc that targets chronic low back and leg pain. Stayble Therapeutics AB (publ) was incorporated in 2015 and is based in Gothenburg, Sweden.

• Industry: Pharmaceutical Preparations
• Founded: 2015
• Employees: 2
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 4K4

Financial Performance

Financial numbers in SEK